Expansion of cancer germline antigen–specific cytotoxic T lymphocytes for immunotherapy
The cancer germline antigens MAGE-A1, MAGE-A3, and NY-ESO-1 can be used to target relapsed or therapy-resistant malignant solid tumors, and previous studies have demonstrated that these antigens can be epigenetically upregulated on the surface of tumor cells following exposure to low-dose demethylat...
| Auteurs principaux: | , , , , |
|---|---|
| Format: | Article |
| Langue: | English |
| Publié: |
IOS Press
2017-07-01
|
| Collection: | Tumor Biology |
| Accès en ligne: | https://doi.org/10.1177/1010428317701309 |